Advertisement

Payer

Five of the 10 drugs with the highest Medicare Part D spending are diabetes treatments, including Ozempic, according to an analysis from KFF. 

Advertisement

From specialty Medicare Advantage plans to continued investment in care delivery services, these are six payers entering new markets, as reported by Becker's since April 1:

Advertisement